Omega TherapeuticsOMGAQ
13F holders, Q2 2025 (June 30)1holders −3
0new positions
3sold out
$0.00avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Omega Therapeutics Inc. (OMGAQ) in their 13F filings, down 3 from Q1 2025. 0 opened new positions and 3 sold out. The largest holder was Huntington National Bank ($0).
- Company
- Omega Therapeutics Inc.
- CUSIP
- 68217N105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $3K |
All 13F filers, Q1 2025 → Q2 2025: 19,648 shares sold, net −19,648 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is OMGAQ's weight in each manager's 13F, not the share of Omega Therapeutics Inc. the manager owns.